Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Classical and Next-Generation Vaccine Platforms to SARS-CoV-2: Biotechnological Strategies and Genomic Variants

18 Feb 2022

Abstract excerpt

Several coronaviruses (CoVs) have been identified as human pathogens, including the α-CoVs strains HCoV-229E and HCoV-NL63 and the β-CoVs strains HCoV-HKU1 and HCoV-OC43. SARS-CoV, MERS-CoV, and SARS-CoV-2 are also classified as β-coronavirus. New SARS-CoV-2 spike genomic variants are responsible for human-to-human and interspecies transmissibility, consequences of adaptations of strains from animals to humans....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to SARS-CoV-2 and COVID-19 Research
Share to SARS-CoV-2 detection and testing
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35206580
DOI: 10.3390/ijerph19042392

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Classical and Next-Generation Vaccine Platforms to SARS-CoV-2: Biotechnological Strategies and Genomic VariantsPMID 35206580Read ↗

COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic StrategiesSemantic proximity Read ↗

SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19Semantic proximity Read ↗

COVID-19 Challenge: A Quest for Effective Vaccine Strategies Against Circulating and Emerging SARS-CoV-2 Variants.Semantic proximity Read ↗

A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 VariantsSemantic proximity Read ↗

Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions.Semantic proximity Read ↗

The Variation of SARS-CoV-2 and Advanced Research on Current VaccinesSemantic proximity Read ↗

Rapidly Evolving SARS-CoV-2: A Brief Review Regarding the Variants and their Effects on Vaccine Efficacies.Semantic proximity Read ↗

Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral Variants.Semantic proximity Read ↗

The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges.Semantic proximity Read ↗

SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants.Semantic proximity Read ↗

Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine EffectivenessSemantic proximity Read ↗

A pan-human coronavirus recombinant vaccine designed from conserved structural epitopes to counter emerging SARS-CoV-2 variantsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.